Experience
Professional experience.
Ee Vin is a Director of Icon Law. He has strong corporate finance and equity capital markets experience and a focus on private credit, funds, alternative investment products, and venture capital. Ee Vin has assisted a broad range of clients with their legal matters, including family offices, venture capital funds, listed companies, and start-ups, often in transactions spanning across Singapore and other Southeast Asian countries such as Indonesia, Vietnam and the Philippines.
Career
Career history.
Ee Vin commenced legal practice in 2017, and worked at boutique and international law firms prior to joining Icon Law. Ee Vin was recognised as a “key lawyer” by the Legal 500 during his time as Senior Associate at said firm. Ee Vin regularly writes legal articles on legal or corporate matters in Singapore and the Southeast Asian region, some of which are accessible on our website. Ee Vin graduated from the Singapore Management University with a Bachelor of Law (Cum Laude) in 2016, and is also a candidate for the Chartered Financial Analyst program
Credentials
Qualifications.
Qualifications
2017 - Qualified Advocate and Solicitor of the Supreme Court of Singapore
2017 - Level 1, Chartered Financial Analyst Program
2016 - Bachelor of Law (Cum Laude), Singapore Management University
Notable Experience
A track record across the region’s markets.
- Acted as Singapore counsel for several international financial institutions in cross-border banking transactions, including without limitation DBS Bank Ltd., China Minsheng Bank and Bank of China Limited.
- Banking and finance, venture debt and other private credit deals, such as acting for: (i) Swettenham Capital Pte. Ltd. as lender of a private credit facility of approximately S$55 million to re-finance and forestall the receivership sale of Link Hotel; (ii) the lenders for a syndicated private credit facility of approximately US$5 million in relation to the borrower’s proposed merger with a special purpose acquisition vehicle; (iii) the lenders for syndicated venture debt facilities to various FinTech and other Southeast Asian-based start-ups; and (iv) the borrowers for a syndicated private credit facility of approximately US$10 million for the expansion of its proprietary salary financing platform.
- Initial public offerings and reverse takeovers of, amongst others: (i) Ardmore Medical Group (now known as Livingstone Health Ltd.) (Singapore Exchange, Catalist); (ii) SBI Offshore Limited (Singapore Exchange, Catalist); and (iii) AsiaPhos Limited (Singapore Exchange, Catalist).
- Mergers and acquisitions, such as acting as Singapore counsel to Semperit Technische Produkte GmbH’s disposal of its medical business (comprising the manufacture, distribution and sale of medical examination and surgical gloves) to HARPS Global Pte Ltd for an enterprise value of approximately €115 million.
- Fund formation and alternative investment products, such as acting as: (i) Singapore legal adviser for a private equity fund with a focus on high-growth disruptive technologies and a targeted fund size of US$100 million; and (ii) legal adviser for the securitisation of a luxury asset valued at approximately €5 million and the offering of said investment product to accredited investors.
- Venture capital funding across different fundraising stages for various start-ups, such as the pre-Series A financing round for a semiconductor solutions and consultancy with a pre-money valuation of S$25 million